|   | |
| Names | |
|---|---|
| Preferred IUPAC name 4-Nitrophenyl 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
|  PubChem CID | |
| UNII | |
|  CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C24H23N3O5 | |
| Molar mass | 433.464 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
JZL195 is a potent inhibitor of both fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), the primary enzymes responsible for degrading the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG), respectively. [1]
| Receptor (ligands) | 
 | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) | 
 | ||||||||||||||||||||||||||||||
| Enzyme (modulators) | 
 | ||||||||||||||||||||||||||||||
| Others | 
 | ||||||||||||||||||||||||||||||
| 
 | |||||||||||||||||||||||||||||||
|   | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. | 
